Amprius Technologies Faces Delisting Concerns

TL;DR

Amprius might get delisted - big trouble for investors.

AI Summary

Amprius Technologies, Inc. filed an 8-K on September 20, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company was formerly known as Kensington Capital Acquisition Corp. IV until a name change on December 14, 2021. The filing indicates potential issues with maintaining its listing on the stock exchange.

Why It Matters

This filing signals potential financial distress or non-compliance with exchange rules, which could lead to the stock being delisted, impacting investor liquidity and valuation.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards is a severe indicator of financial instability or operational issues.

Key Players & Entities

• Amprius Technologies, Inc. (company) — Registrant
• Kensington Capital Acquisition Corp. IV (company) — Former company name
• September 19, 2024 (date) — Earliest event reported date
• September 20, 2024 (date) — Filing date
• December 14, 2021 (date) — Date of name change

FAQ

Key Financial Figures

• $0.0001 — ich registered Common stock, par value $0.0001 per share AMPX The New York Stock Excha
• $11.50 — of common stock at an exercise price of $11.50 AMPX.W The New York Stock Exchange In
• $1.00 — he Company's common stock was less than $1.00 over a consecutive 30 trading-day perio

Filing Documents

• ampx-20240919.htm (8-K) — 30KB
• ampriustechnologiesincpres.htm (EX-99.1) — 10KB
• image_0a.jpg (GRAPHIC) — 7KB
• 0001899287-24-000075.txt ( ) — 219KB
• ampx-20240919.xsd (EX-101.SCH) — 3KB
• ampx-20240919_def.xml (EX-101.DEF) — 16KB
• ampx-20240919_lab.xml (EX-101.LAB) — 28KB
• ampx-20240919_pre.xml (EX-101.PRE) — 16KB
• ampx-20240919_htm.xml (XML) — 4KB

01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On September 19, 2024, Amprius Technologies, Inc. (the "Company") received a notice from the New York Stock Exchange ("NYSE") that it is not in compliance with the continued listing criteria under Section 802.01C of the NYSE Listed Company Manual (the "Listing Rule"), because the average closing price of the Company's common stock was less than $1.00 over a consecutive 30 trading-day period. Under the Listing Rule, the Company has six months from its receipt of the non-compliance notice to cure the deficiency and regain compliance by having a closing price of at least $1.00 per share on the last trading day of any calendar month during the six-month cure period and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month or the last trading day of the cure period. During the six-month cure period, the Company's common stock will continue to be listed and traded on the NYSE, subject to the Company's continued compliance with the NYSE's other applicable listing rules. On September 20, 2024, the Company announced, through a press release, its receipt of the non-compliance notice and its intention to regain compliance. A copy of the press release is attached hereto as Exhibit 99.1.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Amprius Technologies, Inc. Press Release dated September 20, 2024 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AMPRIUS TECHNOLOGIES, INC. Date: September 20, 2024 By: /s/ Sandra Wallach Name: Sandra Wallach Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR